SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:dd77c4c4-ecf6-456a-acb8-ba90b5846e4c"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:dd77c4c4-ecf6-456a-acb8-ba90b5846e4c" > PBX3 is a putative ...

PBX3 is a putative biomarker of aggressive prostate cancer

Ramberg, Håkon (författare)
Oslo university hospital
Grytli, Helene Hartvedt (författare)
Oslo university hospital
Nygård, Ståle (författare)
University of Oslo
visa fler...
Wang, Wanzhong (författare)
Umeå universitet,Umeå University,Patologi,Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Pathol Cytol, Dept Lab Med, Huddinge, Sweden
Ögren, Olov (författare)
Zhao, Sen (författare)
Oslo university hospital,University of Oslo
Løvf, Marthe (författare)
Oslo university hospital,University of Oslo
Katz, Betina (författare)
Oslo university hospital
Skotheim, Rolf I. (författare)
Oslo university hospital,University of Oslo
Bjartell, Anders (författare)
Lund University,Lunds universitet,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,Urological cancer, Malmö,Lund University Research Groups,Skåne University Hospital
Eri, Lars Magne (författare)
Oslo university hospital,University of Oslo
Berge, Viktor (författare)
University of Oslo
Svindland, Aud (författare)
Oslo university hospital,University of Oslo
Taskén, Kristin Austlid (författare)
Oslo university hospital,University of Oslo
visa färre...
 (creator_code:org_t)
2016-06-25
2016
Engelska 11 s.
Ingår i: International Journal of Cancer. - : Wiley. - 0020-7136 .- 1097-0215. ; 139:8, s. 1810-1820
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • There is a great need to identify new and better prognostic and predictive biomarkers to stratify prostate cancer patients for optimal treatment. The aims of this study were to characterize the expression profile of pre-B cell leukemia homeobox (PBX) transcription factors in prostate cancer with an emphasis on investigating whether PBX3 harbours any prognostic value. The expression profile of PBX3 and PBX1 in prostate tissue was determined by immunohistochemical and immunoblot analysis. Furthermore, the expression of PBX3 transcript variants was analyzed by RT-PCR, NanoString Technologies®, and by analyzing RNA sequence data. The potential of PBX3 to predict prognosis, either at mRNA or protein level, was studied in four independent cohorts. PBX3 was mainly expressed in the nucleus of normal prostate basal cells, while it showed cytosolic expression in prostatic intraepithelial neoplasia and cancer cells. We detected four PBX3 transcript variants in prostate tissue. Competing risk regression analysis revealed that high PBX3 expression was associated with slower progression to castration resistant prostate cancer (sub-hazard ratio (SHR) 0.18, 95% CI: 0.081–0.42, p values < 0.001). PBX3 expression had a high predictive accuracy (area under the curve (AUC) = 0.82) when combined with Gleason score and age. Patients undergoing radical prostatectomy, with high levels of PBX3 mRNA, had improved prostate cancer specific survival compared to patients expressing low levels (SHR 0.21, 95% CI: 0.46–0.93, p values < 0.001, and AUC = 0.75). Our findings strongly indicate that PBX3 has potential as a biomarker, both as part of a larger gene panel and as an immunohistochemical marker, for aggressive prostate cancer.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Biomarker
mortality
PBX
prostate cancer

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy